People

People  

 

Meet the Team:

 

Andrew Finnerty - CCMI General Manager

Andrew has 30 years experience in the pharmaceutical manufacturing industry having worked for Warner Lambert, Schering Plough, Organon and Merck Sharpe and Dohme. He has worked extensively in the areas of quality, development, validation and production.  He has significant experience in the areas of aseptic manufacturing and operational management. He has a degree in Biochemistry and an MBA.

Tel: +353 91 494159

Fax: +353 91 495547

Email: andrew.finnerty@nuigalway.ie

 

Prof. Timothy O'Brien - Director of REMEDI

Professor O'Brien established the Regenerative Medicine Institute at NUI, Galway (REMEDI).  The focus of the Institute is to exploit the synergies between the technologies of gene delivery and stem cell biology to promote organ regeneration and repair.  The principal initial disease targets of the Institute are ischaemic cardiovascular disease and osteoarthritis.

 

 

Prof. Frank Barry - Scientific Director of REMEDI

Researcher in the therapeutic application of adult stem cells, especially mesenchymal stem cells (MSCs) from bone marrow.

  

 

 


Mags Desmond - CCMI Quality Manager

Mags has 10 years experience working in the medical device, pharmaceutical and biotech fields.  She has previously worked for Glaxo Smithkline and Boston Scientific.  Her background is in microbiology and she has significant experience in the areas of quality control, manufacturing, quality assurance and compliance.

 

  

Miriam Holohan - CCMI Qualified Person

Miriam has spent over 25 years working in the Pharmaceutical and Medical Device Industry. Her background is primarily as a Qualified Person and in Quality Assurance Management, Miriam has a Higher Diploma in Applied Science and a Masters in Pharmaceutical Sciences. She has extensive experience in all aspects of pharmaceutical manufacturing including project management and providing Technical and Regulatory support. 

 

Dr. Mary Murphy - Lecturer in Regenerative Medicine & Director of Toxicology, REMEDI

The Biology, Mechanism of action and Use of adult stem cells for tissue regeneration in osteoarthritis.

  

Dr, Linda Howard - Lecturer in Regenerative Medicine

Linda investigates how microRNAs regulate the differentiation of MSCs. Linda is also interested in the therapeutic potential of adult stem cells, particularly looking at the nervous, heart and musculoskeletal system.

 

Marc Eglon - QC Coordinator

Marc is responsible for QC testing at CCMI to ensure the quality of raw materials, intermediates and final product, with particular expertise in flow cytometry, karyology, HPLC and cell culture.

Marc joined the REMEDI team in 2004 after working in for 3 years in cell manufacture and now has over 10 years of GMP experience. Marc studied in Glasgow and has BSc(Hons) in Applied Biosciences.

 

Aoife Duffy - CCMI Production Manager

Aoife has over 10 years experience in GMP cell processing. Her background is in quality assurance, compliance, stem cell production, process optimisation and aseptic manufacturing. She has a Masters in Molecular Medicine and a Higher Diploma in Quality Assurance.

 

Georgina Shaw - Acting Production Manager

 

Lisa O’ Reilly - Quality Specialist

Lisa holds an Honours Degree in Microbiology from NUI Galway. Lisa took up employment directly after college with CCMI and she now has three years experience working in a GMP manufacturing environment. Her key responsibilities as a Microbiologist within the organization are the co-ordination of Environmental Monitoring activities, Microbiological testing, materials management and the issuance of controlled documents.

 

Chaansha Shaik Dawood - Stem Cell Technologist

Chaansha holds a Masters Degree in Biotechnology from Bharathiar University, India.Chaansha took up employment with CCMI after working with Stempeutics Research Pvt Ltd.  He has four years experience working in a GMP manufacturing environment.

As a Stem Cell Technologist he is responsible for the large scale expansion (manufacture) of mesenchymal stem cells in a clean room environment. These cells will be used for preclinical studies and clinical studies.

 

NUI, Galway Logo    NCBES Logo    SFI Logo    HEA Logo